<code id='BE676C7C5F'></code><style id='BE676C7C5F'></style>
    • <acronym id='BE676C7C5F'></acronym>
      <center id='BE676C7C5F'><center id='BE676C7C5F'><tfoot id='BE676C7C5F'></tfoot></center><abbr id='BE676C7C5F'><dir id='BE676C7C5F'><tfoot id='BE676C7C5F'></tfoot><noframes id='BE676C7C5F'>

    • <optgroup id='BE676C7C5F'><strike id='BE676C7C5F'><sup id='BE676C7C5F'></sup></strike><code id='BE676C7C5F'></code></optgroup>
        1. <b id='BE676C7C5F'><label id='BE676C7C5F'><select id='BE676C7C5F'><dt id='BE676C7C5F'><span id='BE676C7C5F'></span></dt></select></label></b><u id='BE676C7C5F'></u>
          <i id='BE676C7C5F'><strike id='BE676C7C5F'><tt id='BE676C7C5F'><pre id='BE676C7C5F'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:3117
          Senator Ron Wyden. -- health policy coverage from STAT
          Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee Mariam Zuhaib/AP

          WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that take measures to prevent drug shortages. It also wants to change the way doctors are paid to administer drugs in outpatient settings.

          After a startling number of drugs, including chemotherapies, were in shortage last year, Washington stepped up its efforts to find policy solutions for the problems.

          advertisement

          Most experts say the way that Medicare pays hospitals and doctors, along with the dominance of group purchasing organizations that buy hospital drugs, together force generic drugmakers to cut prices for cheaper generics so low that there is no money left for maintaining facilities or using reliable, diversified supply chains. The result is that facilities get shut down or generic drug manufacturers exit markets, leaving too few makers of drugs to supply demand.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          Setback for rare diseases as Taysha Gene Therapies pulls back
          Setback for rare diseases as Taysha Gene Therapies pulls back

          AdobeIn2020,asbiotechstockssurgedamidthepandemic,astartupcalledTayshaGeneTherapiesraisedover$300mill

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Stroke rates rising, especially in working

          AdobeStrokeprevalencehasbeenclimbingoverthepastdecade,reversingasteadydeclineamongallAmericanswhiler